To include your compound in the COVID-19 Resource Center, submit it here.

Oncodesign leads consortium for AI-based cancer research

In October, Unicancer Group (Paris, France) joined a consortium led by Oncodesign S.A. (Euronext:ALONC) to develop

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE